LAST DECADE DEVELOPMENTS ON LEISHMANIA VACCINES WITH EMPHASIS ON NANOVACCINES

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AKHTARI JAVAD; Soosaraei Masoud; ZIAEI HAJARE; FAKHAR MAHDI

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download Full-Text

Persian Verion

View:

619

Download:

Cites:

Information Journal Paper

Title

LAST DECADE DEVELOPMENTS ON LEISHMANIA VACCINES WITH EMPHASIS ON NANOVACCINES

Author(s)

AKHTARI JAVAD | Soosaraei Masoud | ZIAEI HAJARE | FAKHAR MAHDI | Issue Writer Certificate

Keywords

LEISHMANIASISQ2

NANOVACCINEQ1

LIPOSOMEQ2

NANOPARTICLEQ1

Abstract

LEISHMANIASIS is an infectious disease caused by the protozoan parasites of the genus Leishmania. LEISHMANIASIS annually affects the socioeconomic status of some societies. Evidence show that vaccination could prevent Leishmania and many studies are done on this, particularly nanovacines. So, this article aimed at reviewing recent developments in this field. In current narrative review article, five English databases including Ebsco, Science Direct, PubMed, Google Scholar, and Scopus and four Persian databases including Magiran, Elm Net, Barakat Knowledge Network System, and the Scientific Information Database (SID) were searched for articles published between 2005 and 2016. Current treatment of LEISHMANIASIS is based on chemical drugs but their application is limited due to high cost, toxicity, side effects, and low efficacy. In addition, vaccines can modulate the immune response in removing Leishmania in favor of the hosts. We attempted to review different types of Leishmania vaccine and their development trends, carriers, vaccine candidates, and strategies and delivery systems in last decade. It was found that NANOVACCINEs consisting of multiple antigens and adjuvant are well developed in conjunction with IL-12 as Leish-111f and MPL-SE, therefore, they could be more successful. Current researches on vaccination clearly indicate the need for more research and investment in developing Leishmania vaccine.

Cites

No record.

References

No record.

Cite

APA: Copy

AKHTARI, JAVAD, Soosaraei, Masoud, ZIAEI, HAJARE, & FAKHAR, MAHDI. (2017). LAST DECADE DEVELOPMENTS ON LEISHMANIA VACCINES WITH EMPHASIS ON NANOVACCINES. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 26(146), 232-253. SID. https://sid.ir/paper/45578/en

Vancouver: Copy

AKHTARI JAVAD, Soosaraei Masoud, ZIAEI HAJARE, FAKHAR MAHDI. LAST DECADE DEVELOPMENTS ON LEISHMANIA VACCINES WITH EMPHASIS ON NANOVACCINES. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2017;26(146):232-253. Available from: https://sid.ir/paper/45578/en

IEEE: Copy

JAVAD AKHTARI, Masoud Soosaraei, HAJARE ZIAEI, and MAHDI FAKHAR, “LAST DECADE DEVELOPMENTS ON LEISHMANIA VACCINES WITH EMPHASIS ON NANOVACCINES,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 26, no. 146, pp. 232–253, 2017, [Online]. Available: https://sid.ir/paper/45578/en

Related Journal Papers